MicroStrategy
MSTR
Coinbase
COIN
MARA Holdings
MARA
Meta Platforms
META
NVIDIA
NVDA
US Stock MarketDetailed Quotes
NWBO Northwest Biotherapeutics
- 0.284615
- +0.004715+1.68%
15min DelayClose Jan 6 16:00 ET
375.12MMarket Cap-4.74P/E (TTM)
0.285000High0.276100Low2.60MVolume0.280000Open0.279900Pre Close729.76KTurnover0.22%Turnover RatioLossP/E (Static)1.32BShares0.69500052wk High-4.67P/B343.56MFloat Cap0.24200052wk Low--Dividend TTM1.21BShs Float112.000000Historical High--Div YieldTTM3.18%Amplitude0.140000Historical Low0.281000Avg Price1Lot Size
Northwest Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.07%357K | 153.73%510K | -67.73%284K | 14.80%1.93M | -25.46%445K | 97.09%406K | -57.86%201K | 118.36%880K | 67.46%1.68M | 597K |
| Operating revenue | -12.07%357K | 153.73%510K | -67.73%284K | 14.80%1.93M | -25.46%445K | 97.09%406K | -57.86%201K | 118.36%880K | 67.46%1.68M | --597K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 6.51%15.16M | 30.45%17.97M | 15.78%16.03M | -16.59%57.44M | -16.98%15.59M | -10.07%14.23M | -36.14%13.78M | 9.10%13.84M | 28.22%68.86M | 75.86%18.78M |
| Selling and administrative expenses | -0.03%7.03M | 27.99%9.68M | 15.80%8.09M | -10.92%29.71M | -13.69%8.13M | -13.53%7.03M | -4.63%7.56M | -11.26%6.98M | -0.14%33.35M | 45.19%9.42M |
| -General and administrative expense | -0.03%7.03M | 27.99%9.68M | 15.80%8.09M | -10.92%29.71M | -13.69%8.13M | -13.53%7.03M | -4.63%7.56M | -11.26%6.98M | -0.14%33.35M | 45.19%9.42M |
| Research and development costs | 12.90%8.13M | 33.46%8.29M | 15.76%7.94M | -21.91%27.73M | -20.30%7.45M | -6.41%7.2M | -54.46%6.21M | 42.34%6.86M | 74.86%35.51M | 123.41%9.35M |
| Operating profit | -7.06%-14.8M | -28.63%-17.46M | -21.44%-15.74M | 17.38%-55.51M | 16.70%-15.14M | 11.48%-13.83M | 35.65%-13.58M | -5.52%-12.96M | -27.47%-67.18M | -70.27%-18.18M |
| Net non-operating interest income expense | -24.55%-2.08M | -29.11%-1.68M | -47.81%-1.52M | 13.63%-5.24M | -1.72%-1.24M | -10.45%-1.67M | 9.08%-1.3M | 46.03%-1.03M | -21.09%-6.07M | -5.90%-1.22M |
| Non-operating interest expense | 24.55%2.08M | 29.11%1.68M | 47.81%1.52M | -13.63%5.24M | 1.72%1.24M | 10.45%1.67M | -9.08%1.3M | -46.03%1.03M | 21.09%6.07M | 5.90%1.22M |
| Other net income (expense) | 68.94%-2.49M | 196.06%1.28M | -131.45%-1.05M | 94.18%-1.85M | 127.05%2.41M | 48.94%-8.03M | 106.04%431K | 13,456.00%3.34M | -113.42%-31.78M | -106.13%-8.9M |
| Gain on sale of security | 169.13%4.33M | 164.05%2.12M | -74.43%1.23M | 112.47%3.63M | 166.28%4.24M | 59.00%-6.26M | 111.44%804K | 1,203.22%4.8M | -112.26%-29.13M | -104.40%-6.4M |
| Special income (charges) | -285.75%-6.82M | -93.64%-914K | -54.19%-2.17M | -100.78%-5.4M | 30.77%-1.76M | -287.72%-1.77M | -329.09%-472K | -443.41%-1.41M | -1,530.91%-2.69M | -11,971.43%-2.54M |
| -Less:Other special charges | 285.75%6.82M | 93.64%914K | 54.19%2.17M | 100.78%5.4M | -30.77%1.76M | 287.72%1.77M | 329.09%472K | 443.41%1.41M | 1,530.91%2.69M | 11,971.43%2.54M |
| Other non- operating income (expenses) | ---- | -32.32%67K | -103.85%-106K | -336.36%-78K | ---- | ---- | --99K | ---52K | 105.10%33K | ---- |
| Income before tax | 17.63%-19.37M | -23.68%-17.87M | -71.91%-18.31M | 40.40%-62.6M | 50.61%-13.98M | 28.40%-23.52M | 51.30%-14.45M | 25.06%-10.65M | -158.64%-105.03M | -121.23%-28.3M |
| Income tax | ||||||||||
| Net income | 17.63%-19.37M | -23.68%-17.87M | -71.91%-18.31M | 40.40%-62.6M | 50.61%-13.98M | 28.40%-23.52M | 51.30%-14.45M | 25.06%-10.65M | -158.64%-105.03M | -121.23%-28.3M |
| Net income continuous Operations | 17.63%-19.37M | -23.68%-17.87M | -71.91%-18.31M | 40.40%-62.6M | 50.61%-13.98M | 28.40%-23.52M | 51.30%-14.45M | 25.06%-10.65M | -158.64%-105.03M | -121.23%-28.3M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 17.63%-19.37M | -23.68%-17.87M | -71.91%-18.31M | 40.40%-62.6M | 50.61%-13.98M | 28.40%-23.52M | 51.30%-14.45M | 25.06%-10.65M | -158.64%-105.03M | -121.23%-28.3M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | -74.57%132K | -15.03%441K | 43.80%568K | 1.77M | 341K | 519K | 519K | 395K | 0 | 0 |
| Net income attributable to common stockholders | 18.86%-19.51M | -22.34%-18.31M | -70.91%-18.88M | 38.71%-64.37M | 49.40%-14.32M | 26.82%-24.04M | 49.55%-14.97M | 22.28%-11.05M | -158.64%-105.03M | -121.23%-28.3M |
| Basic earnings per share | 0.00%-0.02 | -100.00%-0.02 | -100.00%-0.02 | 40.00%-0.06 | 50.00%-0.01 | 33.33%-0.02 | 0.00%-0.01 | 0.00%-0.01 | -147.62%-0.1 | -112.50%-0.02 |
| Diluted earnings per share | 0.00%-0.02 | -100.00%-0.02 | -100.00%-0.02 | 40.00%-0.06 | 50.00%-0.01 | 33.33%-0.02 | 0.00%-0.01 | 0.00%-0.01 | -66.67%-0.1 | 0.00%-0.02 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.